
pmid: 4493649
chronic care facility with no hope of improvement. Parkinsonism is a fairly common, disabling, movement disorder caused by dysfunction of the extrapyramidal system. There are 90 to 110 cases per 100,000 people and an annual incidence of 20 cases per 100,000 people in the United States(1). Parkinsonism shortens life, and many patients develop various degrees of disability within four to five years. The longer the disease continues, the more disabling it becomes, with consequent loss of independence. Effective treatment for parkinsonism has been sought for over a century. Nearly fifty years after James Parkinson described this en-
Administration, Oral, Humans, Parkinson Disease, Dihydroxyphenylalanine
Administration, Oral, Humans, Parkinson Disease, Dihydroxyphenylalanine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
